GlassScriptPhysician profile
Emile A Picarella
NPI 1467663906
$1,733.62
in general payments reported to CMS, 2019-2025
20 companies · $95.76 in 2025
The $95.76 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $132 · 2021: $300 · 2022: $436 · 2023: $456 · 2024: $136 · 2025: $95.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $749.64 | 2019-2022 | |
| Abbvie INC. | $332.80 | 2023-2025 | |
| Davol INC. | $149.71 | 2023 | Phasix Mesh |
| Smith+Nephew, INC. | $67.51 | 2021-2022 | |
| Mindray Ds USA, INC. | $53.97 | 2025 | A7 Anesthesia System |
| Sientra, INC. | $44.46 | 2019 | |
| Mentor Worldwide LLC | $42.18 | 2021-2022 | |
| Lifenet Health | $36.56 | 2024 | Theragenesis Wound Matrix |
| Solta Medical, A Division of Bausch Health US, LLC | $35.39 | 2023 | |
| Galderma Laboratories, L.P. | $33.42 | 2019-2023 | |
| Integra Lifesciences Corporation | $32.96 | 2022-2023 | Durasorb Monofilament Mesh |
| Tela Bio, INC. | $28.99 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Peripheral Vascular, INC. | $22.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.08 | 2022 | |
| Kci USA, INC. | $16.59 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $15.75 | 2020 | |
| Trevena, INC. | $15.29 | 2021 | |
| Polynovo North America LLC | $15.11 | 2022 | |
| Organogenesis INC. | $13.49 | 2023 | Puraply |
| Somavac Medical Solutions, INC. | $10.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emile Picarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.